---
title: "Freda: Currently, it has not planned to make ergotamine its main product"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252182820.md"
description: "On August 8th, Freda stated on the interactive platform that the company is currently not planning to make ergotamine its main product"
datetime: "2025-08-08T08:36:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252182820.md)
  - [en](https://longbridge.com/en/news/252182820.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252182820.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/252182820.md) | [繁體中文](https://longbridge.com/zh-HK/news/252182820.md)


# Freda: Currently, it has not planned to make ergotamine its main product

On August 8th, Freda stated on the interactive platform that the company is currently not planning to make ergotamine its main product

### Related Stocks

- [Freda (600223.CN)](https://longbridge.com/en/quote/600223.CN.md)

## Related News & Research

- [Hengrui Pharmaceuticals Obtains Nod for Lung Cancer Combo Drug Trials](https://longbridge.com/en/news/277871128.md)
- [Trelleborg Tightens Climate Goals With SBTi-Validated Net-Zero Path](https://longbridge.com/en/news/278068478.md)
- [U.S. Interior Secretary arrives in Venezuela to discuss energy, minerals](https://longbridge.com/en/news/277804766.md)
- [Hengrui Pharmaceuticals Gets Clinical Trial Nod for Hypertension Drug](https://longbridge.com/en/news/277870666.md)
- [10:51 ETCFX PROJECTS RECEIVE PRESTIGIOUS ACEC 2026 ENGINEERING EXCELLENCE AWARDS](https://longbridge.com/en/news/277806284.md)